Galmed Announces Digital Asset Management Strategy to Enhance Capital Efficiency and Drive Shareholder Value

Core Viewpoint - Galmed Pharmaceuticals Ltd. has approved a digital asset management strategy to diversify its balance sheet and enhance capital efficiency, potentially allocating up to 50% of its cash reserves, approximately $10 million, for digital asset investments [1][2][8] Group 1: Digital Asset Management Strategy - The new treasury investment policy aims to leverage blockchain-based assets for growth and liquidity opportunities [2] - A Crypto Committee has been established to oversee the management of crypto holdings, including portfolio rebalancing, liquidity provisioning, yield-generating protocols, and risk-adjusted hedging strategies [2] - The company has entered into a non-binding letter of intent with Tectona, a crypto treasury management service provider, for advisory and operational services related to digital asset management [3] Group 2: Share Capital Increase - The authorized share capital has been increased from 50,000,000 to 900,000,000 ordinary shares following shareholder approval on August 15, 2025 [4][8] - This increase is intended to provide greater flexibility for the company to raise capital and pursue strategic opportunities [5] Group 3: Management Commentary - The CEO emphasized that integrating digital assets into the treasury management program reflects a proactive approach to financial management and innovation [5] - The strategy aims to optimize liquidity and support the company's mission of advancing transformative therapies [5]